Differential effects of diabetes on CYP2E1 and CYP2B4 proteins and associated drug metabolizing enzyme activities in rabbit liver

Archives of Toxicology

Volumn 79, Issue 8, 2005, Pages 427-433

  Arınç, Emel ^a   Arslan, Şevki ^a   Adalı, Orhan ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Aniline 4 hydroxylase; CYP2B4; CYP2E1; Diabetes; Induction; Rabbit liver

Indexed keywords

4 NITROPHENOL HYDROXYLASE; BENZPHETAMINE; BENZPHETAMINE DEMETHYLASE; CYTOCHROME P450 2B; CYTOCHROME P450 2B4; CYTOCHROME P450 2E1; DRUG METABOLIZING ENZYME; LIVER ENZYME; OXYGENASE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

ALLOXAN DIABETES MELLITUS; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME INDUCTION; IMMUNOBLOTTING; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALIA; CRICETINAE; ORYCTOLAGUS CUNICULUS;

EID: 23944434253     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-005-0654-8     Document Type: Article

References (55)

1. Arinç E (1993) Extrahepatic microsomal forms: Lung microsomal cytochrome P450 isozymes. In: Schenkman JB, Greim H (eds) Handbook of experimental pharmacology, cytochrome P450, vol 105. Springer, Berlin Heidelberg New York, pp 373-386
2. Arinç E, Iscan M (1983) Comparative studies of sheep liver and lung microsomal aniline 4-hydroxylase. Comp Biochem Physiol 74C:151-158
3. Arinç E, Philpot RM (1976) Preparation and properties of partially purified pulmonary cytochrome P-450 from rabbits. J Biol Chem 25:3213-3220
4. Arinç E, Adali O, Iscan MY, Güray T (1991) Stimulatory effects of benzene on rabbit liver and kidney microsomal cytochrome P-450 dependent drug metabolizing enzymes. Arch Toxicol 65:186-190
5. Arinç E, Hanukoglu I, Sen A, Adali O (1995) Tissue-and-species dependent expression of sheep lung microsomal cytochrome P4502B (LgM2). Biochem Mol Biol Int 37:1121-1126
6. Arinç E, Adali O, Gençler-Özkan AM (2000a) Induction of N-nitrosodimethylamine metabolism in liver and lung by in vivo pyridine treatments of rabbits. Arch Toxicol 74:329-334
7. Arinç E, Adali O, Gençler-Özkan AM (2000b) Stimulation of aniline, p-nitrophenol and N-nitrosodimethylamine metabolism in kidney by pyridine treatments of rabbits. Arch Toxicol 74:527-532
8. Barnett CR, Flatt PR, Ionnides C (1990) Induction of hepatic microsomal P450I and IIB proteins by hyperketonaemia. Biochem Pharmacol 40:393-397
9. Billing RE (1985) Mechanism of catechol formation from aromatic compounds in isolated rat hepatocytes. Drug Metab Dispos 13:287-290
10. Bolt HM, Roos PH, Thier R (2003) The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. Int Arch Occup Environ Health 76:174-185
11. Bonfils C, Combalbert J, Pineau T, Angevin J, Larroque C, Derancourt J, Capony JP, Maurel P (1990) Ontogenesis of rabbit liver cytochrome P450. Evidence for a cytochrome P450-IIE (3a)-related form prevailing during the post-natal period. Eur J Biochem 188:187-194
12. Bonfils C, Combalbert J, Pineau T, Larroque C, Lange R, Maurel P (1991) Ontogenesis of liver cytochrome P450. In: Arinc E, Schenkman JB, Hodgson E (eds) Molecular aspects of monooxgenases and bioactivation of toxic compounds NATO ASI series, series A: life sciences, vol 202. Plenum, New York, pp 255-266
13. Chen TL, Chen SH, Tai TY, Chao CC, Park SS, Guengerich FP, Veng TH (1996) Induction and suppression of renal and hepatic cytochrome P450-dependent monooxygenases by acute and chronic streptozotocin diabetes in hamsters. Arch Toxicol 70:202-208
14. Cochin J, Axelrod J (1959) Biochemical and pharmacological changes in the rat following chronic administration of morphine, nalorphine, and normorphine. Pharmacol Exp Ther 125:105-110
15. Ding X, Pernecky JS, Coon MJ (1991) Purification and characterization of cytochrome P4502E2 from hepatic microsomes of neonatal rabbits. Arch Biochem Biophys 291:270-276
16. Dong ZG, Hong JY, Ma QA, Li DC, Bullock J, Gonzalez FJ, Park SS, Gelboin HV, Yang CS (1988) Mechanism of induction of cytochrome P-450ac (P-450j) in chemically induced and spontaneously diabetic rats. Arch Biochem Biophys 263:29-35
17. Ekstrom G, Ingelman-Sundberg M (1989) Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 38:1313-1319
18. Ey PL, Ashman LK (1986) The use of alkaline phosphatase-conjugated anti-immunoglobulin with immunoblots for determining the specificity of monoclonal antibodies to protein mixtures. In: Langone JJ, Vunakis HV (eds) Methods in enzymology, vol 121. Academic, New York, pp 497-509
19. Favreau LV, Schenkman JB (1988) Composition changes in hepatic microsomal cytochrome P450 during onset of streptozotocin-induced diabetes and during insulin treatment. Diabetes 37:577-584
20. Fu X, Chen TS, Ray MB, Nagasawa HT, Williams WM (2004) p-Aminophenol-induced hepatotoxicity in hamsters: role of glutathione. J Biochem Mol Toxicol 18:154-161
21. Funae Y, Imaoka S (1993) Cytochrome P450 in rodents. In: Schenkman JB, Greim H (eds) Handbook of experimental pharmacology, cytochrome P450, vol 105. Springer, Berlin Heidelberg New York, pp 221-238
22. Guengerich FP, Kim DH, Iwasaki M (1991) Role of human cytochrome P450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168-179
23. Haugen DA, Coon MJ (1976) Properties of electrophoretically homogeneous phenobarbital-inducible and β-naphtoflavone-inducible forms of liver microsomal cytochrome P450. J Biol Chem 251:7929-7939
24. Johansson I, Ingelman-Sundberg M (1988) Benzene metabolism by ethanol-inducible, acetone-inducible, and benzene-inducible cytochrome P-450 (IIE1) in rat and rabbit liver microsomes. Cancer Res 48:5387-5390
25. Kharasch ED, Thummel KE (1993) Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology 79:795-807
26. Kim SG, Philpot RM, Novak RF (1991) Pyridine effects on P450IIE1, IIB and IVB expression in rabbit liver: Characterization of high- and low-affinity pyridine N-oxygenases. J Pharmacol Exp Ther 259:470-477
27. Knodell RG, Handwerger BS, Morley JE, Levine AS, Brown DM (1984) Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetus mellitus. J Pharmacol Exp Ther 230:256-262
28. Koop DR (1986) Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P450 isozyme 3a. Mol Pharmacol 29:399-404
29. Koop DR, Morgan ET, Tarr GE, Coon MJ (1982) Purification and characterization of a unique isozyme of cytochrome P450 from liver microsomes of ethanol-treated rabbits. J Biol Chem 257:8472-8480
30. Koop DR, Crump BL, Nordblom GD, Coon MJ (1985) Immunochemical evidence for induction of the alcohol-oxidizing cytochrome P-450 of rabbit liver microsomes by diverse agents: ethanol, imidazole, trichloroethylene, acetone, pyrazole, and isoniazid. Proc Natl Acad Sci USA 82:4065-4069
31. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
32. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ (1951) Protein measurement with the Folin Phenol reagent. J Biol Chem 193:265-275
33. Lu AYH, Levin W (1974) The resolution and reconstitution of the liver microsomal hydroxylation system. Biochem Biophys Acta 344:205-240
34. Nash T (1953) The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J 55:416-421
35. Nebert DW, Gonzales FJ (1987) P-450 genes: structure, evolution, and regulation. Ann Rew Biochem 56:945-993
36. Omura T, Sato R (1964) The carbon monoxide of liver binding pigment of liver microsomes. II. Solubilization, purification, and properties. J Biol Chem 239:2379-2385
37. Öztürk Y, Altan, VM, Yildizoglu-Ari N (1996) Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol Rev 48:69-112
38. Past MR, Cook DE (1982) Effect of diabetes on rat liver cytochrome P-450. Evidence for a unique diabetes-dependent rat liver cytochrome P-450. Biochem Pharmacol 31:3329-3334
39. Peng R, Tennant P, Lorr NA, Yang CS (1983) Alterations of microsomal monooxygenase system and carcinogen metabolism by streptozotocin-induced diabetes in rats. Carcinogenesis 4:703-708
40. Persson JO, Terelius Y, Ingelman-Sundberg M (1990) Cytochrome P-450-dependent formation of reactive oxygen radicals: isozyme-specific inhibition of P-450-mediated reduction of oxygen and carbon tetrachloride. Xenobiotica 20:887-900
41. Peter R, Bocker R, Beaune PH, Iwasaki M, Guengerich FP, Yang CS (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol 3:566-573
42. Raucy JL, Lasker JM, Kraner JC, Salazar DE, Lieber CS, Corcoran GB (1990) Induction of cytochrome P450IIE1 in the obese over-fed rat. Mol Pharmacol 39:275-280
43. Reinke LA, Moyer MJ (1985) p-Nitrophenol hydroxylation. A microsomal oxidation, which is highly inducible by ethanol. Drug Metab Dispos 13:548-552
44. Rich JR, Boobis AR (1997) Expresión and inducibility of P450 enzymes during liver ontogeny. Microsc Res Tech 39:424-435
45. Sakuma T, Honma R, Maguchi S, Tamaki H, Nemoto N (2001) Different expression of hepatic and renal cytochrome P450s between the streptozotocin-induced diabetic mouse and rat. Xenobiotica 31:223-237
46. Serabjit-Sing CJ, Wolf CR, Philpot RM (1979) The rabbit pulmonary monooxygenase system. Immunochemical and biochemical characterization of enzyme components. J Biol Chem 254:9901-9907
47. Shimojo N, Ishizaki T, Imaoka S, Funae Y, Fuji S, Okuda K (1993) Changes in amount of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozotocin-induced diabetes. Biochem Pharmacol 46:621-627
48. Song H, Chen TS (1995) Mouse and rat differences in p-aminophenol toxicity. Toxic Subst Mech 14:307-325
49. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets; procedure and some applications. Proc Nat Acad Sci USA 76:4350-4354
50. Villeneuve JP, Pichette V (2004) Cytochrome p450 and liver diseases. Curr Drug Metab 5:273-282
51. Wang T, Shankar M, Ronis MJJ, Mehendale HM (2000) Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1. J Pharmacol Exp Ther 294:473-479
52. Wang Z, Hall SD, Maya JF, Li L, Asghar A, Gorski JC (2003) Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. Br J Clin Pharmacol 55:77-85
53. Watanabe M (1999) Genetic polymorphisms of cytochrome P450 1A1 and 2E1 and of glutathione S-transferase M1 and cancer susceptibility in the human. In: Arinc E, Schenkman JB, Hodgson E (eds) Molecular and applied aspects of oxidative drug metabolizing enzymes. NATO ASI series, series A: life sciences, vol 303. Kluwer Academic/Plenum, New York, pp 127-143
54. Wolf KK, Wood SG, Bement JL, Sinclair PR, Wrighton SA, Jeffery E, Gonzalez FJ, Sinclair JF (2004) Role of mouse CYP2E1 in the O-hydroxylation of p-nitrophenol: comparison of activities in hepatic microsomes from Cyp2e1 (-/-) and wild-type mice. Drug Metab Dispos 32:681-684
55. Yang CS, Hong JY (1995) Molecular aspects of cytochrome P4502E1 and its roles in chemical toxicology. In: Arinc E, Schenkman JB, Hodgson E (eds) Molecular aspects of oxidative drug metabolizing enzymes: their significance in environmental toxicology, chemical carcinogenesis and health NATO ASI series, series H: cell biology, vol 90. Springer, Berlin Heidelberg New York, pp 181-192